This is a demo store. No orders will be fulfilled.

Grisnilimab (anti-CD7) - Primary antibody, specific to CD7, Mouse IgG2SA

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Mouse
  • Reactive species: Human
  • Isotype: Mouse IgG2a
  • Conjugation: Unconjugated
In stock
Item Number
Ab191904
Grouped product items
SKU Size
Availability
Price Qty
Ab191904-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$89.90
Ab191904-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$419.90
Ab191904-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,329.90
Ab191904-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,199.90

Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Mouse IgG2a; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Grisnilimab (anti-CD7) - Primary antibody, specific to CD7, Mouse IgG2SA
Synonyms CD7 antibody | CD7 antigen (p41) antibody | CD7 antigen antibody | CD7 molecule antibody | CD7_HUMAN antibody | GP40 antibody | LEU 9 antibody | LEU9 antibody | p41 protein antibody | T cell antigen CD7 antibody | T cell leukemia antigen antibody | T cell
Specifications & Purity Carrier Free, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Mouse
Specificity CD7
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Validated
Product Description

Grisnilimab (anti-CD7), a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab (anti-CD7) regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA.

Product Properties

Isotype Mouse IgG2SA
Light Chain Type lambdaC1
SDS-PAGE 144.72 kDa
Purification Method Protein A purified
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2367001-70-3

Associated Targets(Human)

CD7 Tbio T-cell antigen CD7 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Images

Grisnilimab (anti-CD7) (Ab191904) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD7 with Grisnilimab (anti-CD7) (Ab191904) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).

Grisnilimab (anti-CD7) (Ab191904) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD7 (red) with Grisnilimab (anti-CD7) (Ab191904) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.

Grisnilimab (anti-CD7) (Ab191904) - ELISA
Immobilized Recombinant huCD7-ECD-His protein at 2.0 μg/mL can bind Grisnilimab (anti-CD7) (Ab191904) with the EC50 of 25.54 ng/mL.

Grisnilimab (anti-CD7) (Ab191904) - SEC
The purity of Grisnilimab (anti-CD7) (Ab191904) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.